Early Intensive Exercise to Improve Walking in Children With Spastic Diplegia

Sponsor
University of Alberta (Other)
Overall Status
Completed
CT.gov ID
NCT03166293
Collaborator
(none)
4
2
2
41.1
2
0

Study Details

Study Description

Brief Summary

This is a randomized controlled trial comparing 3 months of intensive leg exercise to standard physiotherapy care for the improvement of motor function in the legs in young children with spastic diplegia.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intensive leg training with a physical therapist
N/A

Detailed Description

Children born prematurely are at risk of brain injury that can result in cerebral palsy(CP), most often affecting the legs, called spastic diplegia. Current treatment is largely passive, including leg braces, repeated injection of a paralyzing agent (Botox) in muscles that are abnormally active, and surgery as deformities occur. Active, physical therapy for weak muscles is infrequent, occurring twice a month or less. Yet, recent work with mammals show that early brain injury can be alleviated by intensive exercise therapy, but only while the animal is very young. Building on the success with early, intensive therapy for children with perinatal (around birth) stroke, the investigators will apply intensive therapy for the legs in children with diplegia. Children (8 mo - 3 yr old) will be randomly assigned to start treatment immediately or delay treatment for 3 mo. The delay period controls for improvement without treatment. These children will also receive treatment after the delay period. The therapy will be guided by physical therapists, and similar to the project on perinatal stroke. Children who live beyond commuting distance from the centres will form a 3rd group, whose parents will be coached by therapists to train the child at home. This group will show whether parents can be as effective as a therapist. Finally, when all children turn 4 yr old, they will be compared to other 4-yr-old children with the same diagnosis, but no training, to determine if there are long term benefits. The investigators anticipate that like the children with perinatal stroke, early intensive exercise will improve mobility, facilitate earlier and better walking, and that the effects will be enduring.

Study Design

Study Type:
Interventional
Actual Enrollment :
4 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be randomly assigned to receive 3 months of intervention or 3 months of observation. Participants in the observation group will be offered the intervention once the observation period is completeParticipants will be randomly assigned to receive 3 months of intervention or 3 months of observation. Participants in the observation group will be offered the intervention once the observation period is complete
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Early Intensive Exercise to Improve Walking in Children With Spastic Diplegia From Encephalopathy of Prematurity
Actual Study Start Date :
Jun 1, 2017
Actual Primary Completion Date :
Jan 4, 2019
Actual Study Completion Date :
Nov 3, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Immediate Group

Children will participate in intensive leg training with a physical therapist 1 hour/day, 4 days/week for 12 weeks. Children will continue to receive standard physical therapy care. Children will be followed for one year from the time of enrollment in the study.

Behavioral: Intensive leg training with a physical therapist
Intensive, self initiated activities of the lower extremities including walking over ground or on a treadmill (with or without support), kicking, jumping, standing balance, climbing stairs and slopes and other leg activities. Small weights will be added to the ankle and foot to increase the intensity of the exercise. A physical therapist will supervise sessions.
Other Names:
  • Therapist training
  • Experimental: Delay Group

    Children will be monitored for 3 months with no intervention. Children will participate in intensive leg training with a physical therapist after the 3 month delay period. Training will be 1 hour/day, 4 days/week for 12 weeks. They will continue to receive standard care throughout. Children will be followed for one year from the time of enrollment in the study.

    Behavioral: Intensive leg training with a physical therapist
    Intensive, self initiated activities of the lower extremities including walking over ground or on a treadmill (with or without support), kicking, jumping, standing balance, climbing stairs and slopes and other leg activities. Small weights will be added to the ankle and foot to increase the intensity of the exercise. A physical therapist will supervise sessions.
    Other Names:
  • Therapist training
  • Outcome Measures

    Primary Outcome Measures

    1. Change in Gross Motor Functional Measure - 66 Items (GMFM-66) over 3 months [Baseline, 3 months]

      This is a 66 item criterion-referenced observational measure to assess change in gross motor function of children with cerebral palsy.

    Secondary Outcome Measures

    1. Change in forces during treadmill walking over 3 months [Baseline, 3 months]

      The child will be supported to walk on a treadmill while we record the leg motions and the forces under the feet during walking.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    8 Months to 36 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • children aged 8 mo - 3 yr old

    • Evidence of periventricular white matter injury on diagnostic imaging

    • clinical evidence of spastic diplegia

    Exclusion Criteria:
    • born before gestational age of 25 weeks

    • birth weight <1000g (to exclude confounds related to extreme prematurity and low birth weights)

    • MRI evidence of diffuse injury to the cerebral or cerebellar cortex

    • uncontrolled epilepsy or infantile spasms in the past 6 months (contraindication for TMS)

    • cardiovascular or musculoskeletal complications that preclude participation in intensive exercise

    • Botulinum toxin (BTX-A) injections in the last 6 months

    • Predicted GMFCS 4 or 5

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Alberta Children's Hospital Calgary Alberta Canada
    2 University of Alberta Edmonton Alberta Canada T6G 2G4

    Sponsors and Collaborators

    • University of Alberta

    Investigators

    • Principal Investigator: Jaynie Yang, PhD, University of Alberta
    • Principal Investigator: Monica Gorassini, PhD, University of Alberta

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Alberta
    ClinicalTrials.gov Identifier:
    NCT03166293
    Other Study ID Numbers:
    • Pro00072587
    First Posted:
    May 25, 2017
    Last Update Posted:
    Nov 5, 2020
    Last Verified:
    Nov 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Alberta
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 5, 2020